BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25086470)

  • 1. A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Hiligsmann M; Cooper C; Guillemin F; Hochberg MC; Tugwell P; Arden N; Berenbaum F; Boers M; Boonen A; Branco JC; Maria-Luisa B; Bruyère O; Gasparik A; Kanis JA; Kvien TK; Martel-Pelletier J; Pelletier JP; Pinedo-Villanueva R; Pinto D; Reiter-Niesert S; Rizzoli R; Rovati LC; Severens JL; Silverman S; Reginster JY
    Semin Arthritis Rheum; 2014 Dec; 44(3):271-82. PubMed ID: 25086470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Hiligsmann M; Cooper C; Arden N; Boers M; Branco JC; Luisa Brandi M; Bruyère O; Guillemin F; Hochberg MC; Hunter DJ; Kanis JA; Kvien TK; Laslop A; Pelletier JP; Pinto D; Reiter-Niesert S; Rizzoli R; Rovati LC; Severens JL; Silverman S; Tsouderos Y; Tugwell P; Reginster JY
    Semin Arthritis Rheum; 2013 Dec; 43(3):303-13. PubMed ID: 23992801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Honvo G; Bannuru RR; Bruyère O; Rannou F; Herrero-Beaumont G; Uebelhart D; Cooper C; Arden N; Conaghan PG; Reginster JY; Thomas T; McAlindon T
    Drugs Aging; 2019 Apr; 36(Suppl 1):145-159. PubMed ID: 31073927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Bruyère O; Honvo G; Veronese N; Arden NK; Branco J; Curtis EM; Al-Daghri NM; Herrero-Beaumont G; Martel-Pelletier J; Pelletier JP; Rannou F; Rizzoli R; Roth R; Uebelhart D; Cooper C; Reginster JY
    Semin Arthritis Rheum; 2019 Dec; 49(3):337-350. PubMed ID: 31126594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.
    Hiligsmann M; Reginster JY; Tosteson ANA; Bukata SV; Saag KG; Gold DT; Halbout P; Jiwa F; Lewiecki EM; Pinto D; Adachi JD; Al-Daghri N; Bruyère O; Chandran M; Cooper C; Harvey NC; Einhorn TA; Kanis JA; Kendler DL; Messina OD; Rizzoli R; Si L; Silverman S
    Osteoporos Int; 2019 Jan; 30(1):45-57. PubMed ID: 30382319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
    Hochberg MC; Altman RD; April KT; Benkhalti M; Guyatt G; McGowan J; Towheed T; Welch V; Wells G; Tugwell P;
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):465-74. PubMed ID: 22563589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis.
    Cochrane T; Davey RC; Matthes Edwards SM
    Health Technol Assess; 2005 Aug; 9(31):iii-iv, ix-xi, 1-114. PubMed ID: 16095546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing obesity in the management of knee and hip osteoarthritis - weighing in from an economic perspective.
    Flego A; Dowsey MM; Choong PF; Moodie M
    BMC Musculoskelet Disord; 2016 May; 17():233. PubMed ID: 27229924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review.
    Pinto D; Robertson MC; Hansen P; Abbott JH
    Value Health; 2012 Jan; 15(1):1-12. PubMed ID: 22264966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working Group.
    Rolfson O; Wissig S; van Maasakkers L; Stowell C; Ackerman I; Ayers D; Barber T; Benzakour T; Bozic K; Budhiparama N; Caillouette J; Conaghan PG; Dahlberg L; Dunn J; Grady-Benson J; Ibrahim SA; Lewis S; Malchau H; Manzary M; March L; Nassif N; Nelissen R; Smith N; Franklin PD
    Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1631-1639. PubMed ID: 26881821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2007 Sep; 15(9):981-1000. PubMed ID: 17719803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: Consensus of a Working Group of the European Society on Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Reginster JL; Arden NK; Haugen IK; Rannou F; Cavalier E; Bruyère O; Branco J; Chapurlat R; Collaud Basset S; Al-Daghri NM; Dennison EM; Herrero-Beaumont G; Laslop A; Leeb BF; Maggi S; Mkinsi O; Povzun AS; Prieto-Alhambra D; Thomas T; Uebelhart D; Veronese N; Cooper C
    Semin Arthritis Rheum; 2018 Aug; 48(1):1-8. PubMed ID: 29287769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2008 Feb; 16(2):137-62. PubMed ID: 18279766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of economic evaluations investigating education, exercise, and dietary weight management to manage hip and knee osteoarthritis: protocol.
    Mazzei DR; Ademola A; Abbott JH; Sajobi T; Hildebrand K; Marshall DA
    Syst Rev; 2020 Oct; 9(1):229. PubMed ID: 33023665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PANLAR Consensus Recommendations for the Management in Osteoarthritis of Hand, Hip, and Knee.
    Rillo O; Riera H; Acosta C; Liendo V; Bolaños J; Monterola L; Nieto E; Arape R; Franco LM; Vera M; Papasidero S; Espinosa R; Esquivel JA; Souto R; Rossi C; Molina JF; Salas J; Ballesteros F; Radrigan F; Guibert M; Reyes G; Chico A; Camacho W; Urioste L; Garcia A; Iraheta I; Gutierrez CE; Aragón R; Duarte M; Gonzalez M; Castañeda O; Angulo J; Coimbra I; Munoz-Louis R; Saenz R; Vallejo C; Briceño J; Acuña RP; De León A; Reginato AM; Möller I; Caballero CV; Quintero M
    J Clin Rheumatol; 2016 Oct; 22(7):345-54. PubMed ID: 27660931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.
    Kolasinski SL; Neogi T; Hochberg MC; Oatis C; Guyatt G; Block J; Callahan L; Copenhaver C; Dodge C; Felson D; Gellar K; Harvey WF; Hawker G; Herzig E; Kwoh CK; Nelson AE; Samuels J; Scanzello C; White D; Wise B; Altman RD; DiRenzo D; Fontanarosa J; Giradi G; Ishimori M; Misra D; Shah AA; Shmagel AK; Thoma LM; Turgunbaev M; Turner AS; Reston J
    Arthritis Rheumatol; 2020 Feb; 72(2):220-233. PubMed ID: 31908163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy.
    Bernetti A; Mangone M; Villani C; Alviti F; Valeo M; Grassi MC; Migliore A; Viora U; Adriani E; Quirino N; Fioravanti A; Paoloni M
    Eur J Phys Rehabil Med; 2019 Oct; 55(5):658-664. PubMed ID: 31106560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
    Bruyère O; Cooper C; Pelletier JP; Branco J; Luisa Brandi M; Guillemin F; Hochberg MC; Kanis JA; Kvien TK; Martel-Pelletier J; Rizzoli R; Silverman S; Reginster JY
    Semin Arthritis Rheum; 2014 Dec; 44(3):253-63. PubMed ID: 24953861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO).
    Biver E; Berenbaum F; Valdes AM; Araujo de Carvalho I; Bindels LB; Brandi ML; Calder PC; Castronovo V; Cavalier E; Cherubini A; Cooper C; Dennison E; Franceschi C; Fuggle N; Laslop A; Miossec P; Thomas T; Tuzun S; Veronese N; Vlaskovska M; Reginster JY; Rizzoli R
    Ageing Res Rev; 2019 Nov; 55():100946. PubMed ID: 31437484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature.
    Kamaruzaman H; Kinghorn P; Oppong R
    BMC Musculoskelet Disord; 2017 May; 18(1):183. PubMed ID: 28486957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.